Project | Scope Scope |
The initial scope of the project is guidance on the use of open-source projects, as well as collaboration on and creation of open-source projects. The primary aim is to provide guidance and link out to more information. If gaps are found, they will be noted for later follow-up and potential follow-on working groups:
|
Project Leads | |
---|---|
Mike Stackhouse |
, Atorus Research |
mike.stackhouse@atorusresearch.com | |
James Black |
, Roche |
James.black.jb2@roche.com |
Nicola Newton, PHUSE Project Assistant |
| |||||||
Project to close after their talk at the EU Connect. |
Objectives & Deliverables | Timelines |
---|---|
Create a living guidance document (using a tool like MkDocs or GitBook) that provides a reference document for open-source collaboration for pharma companies | Q1 – Q2 2022 |
Release white paper as static snapshot of v1.0 of the guidance | Q2 2023 |
| |||||||
Project are working on white paper. | |||||||
Project Members | Organisation | ||||||
---|---|---|---|---|---|---|---|
Anders Bilgrau | Novo Nordisk | ||||||
Bhargavi Raghavan | Takeda | ||||||
Bhavin Busa | Independent | ||||||
Estella Dong | Bayer | ||||||
Jesper Zeth | Novo Nordisk | ||||||
Karan Dheer | SAS | ||||||
Keaven Anderson | Merck | ||||||
Lyn Taylor | Parexel | ||||||
Sam Hume | CDISC |